More on EYPT

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (2.9 Score)

Upcoming Events

- Earnings (11/4/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

EyePoint Pharmaceuticals (NQ:EYPT)
Delayed: 0.40 -0.03 (6.98%)
Prev. Close $0.43  
Open$0.42 
52 Wk High$ 
52 Wk Low$ 
Day High$0.43 
Day Low$0.40 
P/E N/A  
EPS$ 
Volume13,328,736 

Friends, Peers and Foes (?): APLS, RVMD, OCUL, REGN, AMGN (more...)

Oct 23, 2026 04:08 PM Jones Trading Downgrades EyePoint Inc. (EYPT) to Hold
Oct 20, 2026 08:44 AM Laidlaw Downgrades EyePoint Inc. (EYPT) to Hold
Oct 20, 2026 05:50 AM EyePoint Inc. (EYPT) PT Lowered to $1 at RBC Capital
Oct 20, 2026 05:31 AM Mizuho Downgrades EyePoint Inc. (EYPT) to Neutral 'on Negative P3 Data, Lack of Catalysts, Financing Overhang'
Oct 20, 2026 03:33 AM JPMorgan Downgrades EyePoint Inc. (EYPT) to Underweight
Oct 19, 2026 12:50 PM Guggenheim Downgrades EyePoint Inc. (EYPT) to Neutral
Oct 19, 2026 10:00 AM Jefferies Downgrades EyePoint Inc. (EYPT) to Hold
Oct 19, 2026 09:38 AM EyePoint crashes as pivotal wet AMD trial fails, prompting 53% workforce cut
Oct 19, 2026 09:22 AM Form 8-K EyePoint, Inc. For: Oct 17
Oct 19, 2026 07:16 AM EyePoint cuts 53% of workforce after wet AMD trial failure
View All Articles

Entities mentioned with EYPT

View All Entities